Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 5/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.35 |
| ▸ | HPGD | P15428 | 4/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.34 |
| ▸ | F9 | P00740 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 3/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.34 |
| ▸ | RELA | Q04206 | 1/20 | 0.34 |
| ▸ | ATM | Q13315 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | GPR3 | P46089 | 1/20 | 0.33 |
| ▸ | PRKDC | P78527 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23822796 | 0.98 | MAPT (0.34) | MAPTALDH1A1HPGDSMN1; SMN2RAB9A | |
| SCHEMBL25668695 | 0.97 | ALOX5 (0.35) | MAPTALDH1A1HPGDSMN1; SMN2RAB9A | |
| SCHEMBL25947253 | 0.97 | PLA2G2A (0.36) | MAPTALDH1A1HPGDSMN1; SMN2RAB9A | |
| SCHEMBL25645977 | 0.97 | PLA2G2A (0.36) | MAPTALDH1A1HPGDSMN1; SMN2RAB9A | |
| SCHEMBL24216567 | 0.95 | PRKDC (0.36) | MAPTALDH1A1HPGDSMN1; SMN2RAB9A | |
| SCHEMBL22330214 | 0.95 | PIM3 (0.33) | MAPTALDH1A1HPGDSMN1; SMN2RAB9A | |
| SCHEMBL22329713 | 0.95 | PIM3 (0.33) | MAPTALDH1A1HPGDSMN1; SMN2RAB9A | |
| SCHEMBL23822138 | 0.95 | MAPT (0.34) | MAPTALDH1A1HPGDSMN1; SMN2RAB9A | |
| SCHEMBL23822136 | 0.95 | MAPT (0.34) | MAPTALDH1A1HPGDSMN1; SMN2RAB9A | |
| SCHEMBL24315476 | 0.95 | F9 (0.37) | MAPTALDH1A1HPGDSMN1; SMN2RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4276924-A1 | ORGANIC LIGHT EMITTING DEVICE | Lg Chem, Ltd. (KR) | 2023-11-15 | — | — | EP | disclosed |
| US-20230354706-A1 | ORGANIC LIGHT EMITTING DEVICE | LG CHEM, LTD. (KR) | 2023-11-02 | — | — | US | disclosed |
| US-20230354706-A1 | ORGANIC LIGHT EMITTING DEVICE | LG CHEM, LTD. (KR) | 2023-11-02 | — | — | US | disclosed |
| EP-4258372-A1 | ORGANIC LIGHT-EMITTING DEVICE | Lg Chem, Ltd. (KR) | 2023-10-11 | — | — | EP | disclosed |
| EP-4254527-A1 | ORGANIC LIGHT EMITTING DEVICE | Lg Chem, Ltd. (KR) | 2023-10-04 | — | — | EP | disclosed |
| EP-4243100-A1 | ORGANIC LIGHT-EMITTING DEVICE | Lg Chem, Ltd. (KR) | 2023-09-13 | — | — | EP | disclosed |
| EP-4235829-A1 | ORGANIC LIGHT-EMITTING DEVICE | Lg Chem, Ltd. (KR) | 2023-08-30 | — | — | EP | disclosed |
| EP-4235830-A1 | ORGANIC LIGHT-EMITTING DEVICE | Lg Chem, Ltd. (KR) | 2023-08-30 | — | — | EP | disclosed |
| WO-2023132694-A1 | ORGANIC LIGHT-EMITTING DEVICE | 주식회사 엘지화학 | 2023-07-13 | — | — | WO | disclosed |
| EP-3972001-B1 | ORGANIC LIGHT EMITTING DEVICE | LG CHEMICAL LTD (KR) | 2023-06-21 | — | — | EP | disclosed |
| WO-2022177374-A1 | ORGANIC LIGHT-EMITTING DEVICE | 주식회사 엘지화학 | 2022-08-25 | — | — | WO | disclosed |
| EP-3972001-A1 | ORGANIC LIGHT EMITTING DEVICE | LG Chem, Ltd. (KR) | 2022-03-23 | — | — | EP | disclosed |
| US-9585884-B2 | Pyrimidinone inhibitors of lipoprotein-associated phospholipase A2 | AUSPEX PHARMACEUTICALS, INC. (US) | 2017-03-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230354706-A1 | ORGANIC LIGHT EMITTING DEVICE | CRY2, CRY1, PER2 | MAPT 1053/4885ALDH1A1 48/4885HPGD 689/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.